Parameters | Group 1 ≥ 65 Age (n:156) | Group 2 ≤ 45 Age (n:124) | p-value |
---|---|---|---|
Gender | 0.007 | ||
Male | 121 (%77.6) | 78 (%62.9) | |
Female | 35 (%22.4) | 46 (%37.1) | |
BMI (kg/m2) | 25.9 ± 4.6 | 25.9 ± 5.1 | 0.999 |
ASA Classification | 3 (1–4) | 2 (1–4) | < 0.001 |
Comorbidities | 131 (%84.0) | 42 (%33.9) | < 0.001 |
DM | 33 (%21.2) | 4 (%3.2) | < 0.001 |
HT | 68 (%43.6) | 6 (%4.8) | < 0.001 |
CAD | 32 (%20.5) | 3 (%2.4) | < 0.001 |
COPD | 25 (%16.0) | 1 (%0.8) | < 0.001 |
FEV1% | 74 (23–169) | 88 (39–133) | < 0.001 |
FVC % | 74 (22–147) | 89 (40–126) | < 0.001 |
FEV1/FVC % | 76 (47–100) | 82 (68–99) | < 0.001 |
Initial hemodynamics | |||
MBP (mmHg) | 93.1 ± 13.0 | 88.4 ± 9.9 | < 0.001 |
HR (beat/min) | 81.9 ± 13.3 | 84.9 ± 12.7 | 0.064 |
SpO2 (%) | 96.1 ± 2.3 | 96.7 ± 1.8 | 0.027 |